OPK News and Press, Opko Health Inc.

2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...

NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...

MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be holding one-on-one meetings with ...

2024-05-07 21:15:17 ET Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q1 2024 Earnings Call May 07, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q1 2024 Earnings Call Transcript

2024-05-07 20:03:09 ET Start Time: 16:30 End Time: 17:21 OPKO Health, Inc. (OPK) Q1 2024 Earnings Conference Call May 07, 2024, 16:30 PM ET Company Participants Phil Frost - Chairman and CEO Elias Zerhouni - President and Vice Chairman Adam Logal - SVP an...

2024-05-07 16:49:09 ET More on OPKO Health OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript Labcorp to buy select assets from OPKO’s BioReference Health Seeking Alpha’s Quant Rating on OPKO Health Historical earnings data for OPKO Health...

2024-05-07 16:22:13 ET More on OPKO Health OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript Labcorp to buy select assets from OPKO’s BioReference Health Seeking Alpha’s Quant Rating on OPKO Health Historical earnings data for OPKO Health...

MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select ass...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business upda...